Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 3, 2008, Pages 607-617

  Dai, Ying ^a,b   Ashraf, Muhammad ^a   Zuo, Shi ^a   Uemura, Ryota ^a   Dai, Yan Shan ^a   Wang, Yigang ^a   Haider, Husnain Kh ^a   Li, Tingyu ^b   Xu, Meifeng ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; BMSCs; Cytoprotective protein; G CSF; GATA 4; Ischemia; Mobilization; Progenitor cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PROTEIN BCL 2; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL MOBILIZATION; TISSUE REGENERATION;

ANIMALS; BONE MARROW CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GATA4 TRANSCRIPTION FACTOR; GRANULOCYTE COLONY-STIMULATING FACTOR; MALE; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

MUS;

EID: 40649104083     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.11.011     Document Type: Article

References (47)

1. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 102 (2005) 8692-8697
2. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111 (2005) 11-20
3. Zeng L., Hu Q., Wang X., Mansoor A., Lee J., Feygin J., et al. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115 (2007) 1866-1875
4. Nagaya N., Kangawa K., Itoh T., Iwase T., Murakami S., Miyahara Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005) 1128-1135
5. Kudo M., Wang Y., Wani M.A., Xu M., Ayub A., and Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 35 (2003) 1113-1119
6. Muller-Eh1msen J., Krausgrill B., Burst V., Schenk K., Neisen U.C., Fries J.W., et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41 (2006) 876-884
7. Leone A.M., Rutella S., Bonanno G., Abbate A., Rebuzzi A.G., Giovannini S., et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26 (2005) 1196-1204
8. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
9. Spevack D.M., Cavaleri S., Zolotarev A., Liebes L., Inghirami G., Tunick P.A., et al. Increase in circulating bone marrow progenitor cells after myocardial infarction. Coron Artery Dis 17 (2006) 345-349
10. Aicher A., Brenner W., Zuhayra M., Badorff C., Massoudi S., Assmus B., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107 (2003) 2134-2139
11. Tomoda H., and Aoki N. Bone marrow stimulation and left ventricular function in acute myocardial infarction. Clin Cardiol 26 (2003) 455-457
12. Tatsumi T., Ashihara E., Yasui T., Matsunaga S., Kido A., Sasada Y., et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J Off J Jpn Circ Soc 71 (2007) 1199-1207
13. Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 (2005) I178-I183
14. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
15. Fukuhara S., Tomita S., Nakatani T., Ohtsu Y., Ishida M., Yutani C., et al. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant 13 (2004) 741-748
16. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
17. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Amano K., Iba O., et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol 22 (2002) 1804-1810
18. Maruyama K., Mori Y., Murasawa S., Masaki H., Takahashi N., Tsutusmi Y., et al. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol 31 (1999) 607-617
19. Giulian D., Woodward J., Young D.G., Krebs J.F., and Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8 (1988) 2485-2490
20. Leone A.M., Rutella S., Bonanno G., Contemi A.M., de Ritis D.G., Giannico M.B., et al. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol 111 (2006) 202-208
21. Kawada H., Fujita J., Kinjo K., Matsuzaki Y., Tsuma M., Miyatake H., et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104 (2004) 3581-3587
22. Wang Y., Haider H.K., Ahmad N., Xu M., Ge R., and Ashraf M. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 40 (2006) 736-745
23. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98 (2006) 1414-1421
24. Xu M., Wang Y., Ayub A., and Ashraf M. Mitochondrial K(ATP) channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am J Physiol Heart Circ Physiol 281 (2001) H1295-H1303
25. Dai Y., Xu M., Wang Y., Pasha Z., Li T., and Ashraf M. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 42 (2007) 1036-1044
26. Xu M., Wani M., Dai Y.-S., Wang J., Yan M., Ayub A., et al. Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 110 (2004) 2658-2665
27. Dai Y.S., and Markham B.E. p300 Functions as a coactivator of transcription factor GATA-4. J Biol Chem 276 (2001) 37178-37185
28. Gindraux F., Selmani Z., Obert L., Davani S., Tiberghien P., Herve P., et al. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res 327 (2007) 471-483
29. Sabatini F., Petecchia L., Tavian M., Jodon de Villeroche V., Rossi G.A., and Brouty-Boye D. Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest J Tech Methods Pathol 85 (2005) 962-971
30. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
31. Kleinschnitz C., Schroeter M., Jander S., and Stoll G. Induction of granulocyte colony-stimulating factor mRNA by focal cerebral ischemia and cortical spreading depression. Brain Res Mol Brain Res 131 (2004) 73-78
32. Zhang Y., Woodward V.K., Shelton J.M., Richardson J.A., Zhou X.J., Link D., et al. Ischemia-reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro. Am J Physiol Renal Physiol 286 (2004) F1193-F1201
33. Hierholzer C., Kalff J.C., Audolfsson G., Billiar T.R., Tweardy D.J., and Bauer A.J. Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injury. Transplantation 68 (1999) 1244-1254
34. Vandervelde S., van Luyn M.J., Rozenbaum M.H., Petersen A.H., Tio R.A., and Harmsen M.C. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc Res 73 (2007) 783-793
35. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3] (2002) 687-694
36. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., and Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300-3305
37. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275 (2000) 38949-38952
38. Grepin C., Nemer G., and Nemer M. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development 124 (1997) 2387-2395
39. Grepin C., Robitaille L., Antakly T., and Nemer M. Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol Cell Biol 15 (1995) 4095-4102
40. Fuchs S., Baffour R., Zhou Y.F., Shou M., Pierre A., Tio F.O., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37 (2001) 1726-1732
41. Tang Y.L., Zhao Q., Zhang Y.C., Cheng L., Liu M., Shi J., et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117 (2004) 3-10
42. Torella D., Rota M., Nurzynska D., Musso E., Monsen A., Shiraishi I., et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 94 (2004) 514-524
43. Kitta K., Day R.M., Ikeda T., and Suzuki Y.J. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med 31 (2001) 902-910
44. Li W., Ma N., Ong L.L., Nesselmann C., Klopsch C., Ladilov Y., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells (Dayton, Ohio) 25 (2007) 2118-2127
45. Xu M., Uemura R., Dai Y., Wang Y., Pasha Z., and Ashraf M. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 42 (2007) 441-448
46. Mayorga M., Bahi N., Ballester M., Comella J.X., and Sanchis D. Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death. J Biol Chem 279] (2004) 34882-34889
47. Kobayashi S., Lackey T., Huang Y., Bisping E., Pu W.T., Boxer L.M., et al. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J Off Pub Fed Am Soc Exp Biol 20 (2006) 800-802